In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies

American Journal of Obstetrics and Gynecology

Volumn 215, Issue 6, 2016, Pages 782.e1-782.e9

  Holme, Ane M ^a   Roland, Marie C P ^a,b   Henriksen, Tore ^a,c   Michelsen, Trond M ^a,d  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b Vestre Viken Hospital Trust   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

human; in vivo; placenta; PlGF; preeclampsia; sFlt 1

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 1; PLACENTAL GROWTH FACTOR; FLT1 PROTEIN, HUMAN; VASCULOTROPIN RECEPTOR 1;

ADULT; CASE CONTROL STUDY; CEPHALIC VEIN; CESAREAN SECTION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GESTATIONAL AGE; HUMAN; IN VIVO STUDY; PLACENTA FUNCTION; PLACENTA WEIGHT; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; RANK SUM TEST; WILCOXON SIGNED RANKS TEST; ARM; BLOOD; METABOLISM; PLACENTA; RADIAL ARTERY; UTERUS; VASCULARIZATION; VEIN;

ADULT; ARM; CASE-CONTROL STUDIES; FEMALE; HUMANS; PLACENTA; PLACENTA GROWTH FACTOR; PRE-ECLAMPSIA; PREGNANCY; RADIAL ARTERY; UTERUS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VEINS;

EID: 85006256241     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2016.07.056     Document Type: Conference Paper

References (33)

1. 1 Redman, C.W., Sargent, I.L., Staff, A.C., IFPA Senior Award Lecture: making sense of pre-eclampsia: two placental causes of preeclampsia?. Placenta 35:suppl (2014), S20–S25.
2. 2 Myatt, L., Roberts, J.M., Preeclampsia: syndrome or disease?. Curr Hypertens Rep, 17, 2015, 83.
3. 3 Sibai, B., Dekker, G., Kupferminc, M., Pre-eclampsia. Lancet 365 (2005), 785–799.
4. 4 Huppertz, B., Maternal-fetal interactions, predictive markers for preeclampsia, and programming. J Reprod Immunol 108 (2015), 26–32.
5. 5 Roberts, J.M., Taylor, R.N., Musci, T.J., Rodgers, G.M., Hubel, C.A., McLaughlin, M.K., Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161 (1989), 1200–1204.
6. 6 Maynard, S.E., Min, J.Y., Merchan, J., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111 (2003), 649–658.
7. 7 Levine, R.J., Maynard, S.E., Qian, C., et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350 (2004), 672–683.
8. 8 Taylor, R.N., Grimwood, J., Taylor, R.S., McMaster, M.T., Fisher, S.J., North, R.A., Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol 188 (2003), 177–182.
9. 9 Chaiworapongsa, T., Romero, R., Espinoza, J., et al. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia: Young Investigator Award. Am J Obstet Gynecol 190 (2004), 1541–1550.
10. 10 Torry, D.S., Wang, H.S., Wang, T.H., Caudle, M.R., Torry, R.J., Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol 179 (1998), 1539–1544.
11. 11 Liu, Y., Zhao, Y., Yu, A., Zhao, B., Gao, Y., Niu, H., Diagnostic accuracy of the soluble Fms-like tyrosine kinase-1/placental growth factor ratio for preeclampsia: a meta-analysis based on 20 studies. Arch Gynecol Obstet 292 (2015), 507–518.
12. 12 Zeisler, H., Llurba, E., Chantraine, F., et al. Predictive falue of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med 374 (2016), 13–22.
13. 13 Myers, J.E., Kenny, L.C., McCowan, L.M., et al. Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study. BJOG 120 (2013), 1215–1223.
14. 14 Kleinrouweler, C.E., Wiegerinck, M.M., Ris-Stalpers, C., et al. Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis. BJOG 119 (2012), 778–787.
15. 15 Zhou, Y., McMaster, M., Woo, K., et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 160 (2002), 1405–1423.
16. 16 Gu, Y., Lewis, D.F., Wang, Y., Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies. J Clin Endocrinol Metab 93 (2008), 260–266.
17. 17 Ahmad, S., Ahmed, A., Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res 95 (2004), 884–891.
18. 18 Ahmed, A., Dunk, C., Ahmad, S., Khaliq, A., Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen: a review. Placenta 21:suppl A (2000), S16–S24.
19. 19 Khaliq, A., Dunk, C., Jiang, J., et al. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for “placental hyperoxia” in intrauterine growth restriction. Lab Invest 79 (1999), 151–170.
20. 20 Bujold, E., Romero, R., Chaiworapongsa, T., et al. Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin. J Matern Fetal Neonatal Med 18 (2005), 9–16.
21. 21 Paasche Roland, M.C., Lorentzen, B., Godang, K., Henriksen, T., Uteroplacental arterio-venous difference in soluble VEGFR-1 (sFlt-1), but not in soluble endoglin concentrations in preeclampsia. Placenta 33 (2012), 224–226.
22. 22 Rajakumar, A., Michael, H.M., Rajakumar, P.A., et al. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women. Placenta 26 (2005), 563–573.
23. 23 Yonekura, H., Sakurai, S., Liu, X., et al. Placenta growth factor and vascular endothelial growth factor B and C expression in microvascular endothelial cells and pericytes. Implication in autocrine and paracrine regulation of angiogenesis. J Biol Chem 274 (1999), 35172–35178.
24. 24 Torry, D.S., Mukherjea, D., Arroyo, J., Torry, R.J., Expression and function of placenta growth factor: implications for abnormal placentation. J Soc Gynecol Investig 10 (2003), 178–188.
25. 25 Weissgerber, T.L., Rajakumar, A., Myerski, A.C., et al. Vascular pool of releasable soluble VEGF receptor-1 (sFLT1) in women with previous preeclampsia and uncomplicated pregnancy. J Clin Endocrinol Metab 99 (2014), 978–987.
26. 26 Sandvik, M.K., Leirgul, E., Nygard, O., et al. Preeclampsia in healthy women and endothelial dysfunction 10 years later. Am J Obstet Gynecol 209 (2013), 569.e1–569.e10.
27. 27 Wolf, M., Hubel, C.A., Lam, C., et al. Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. J Clin Endocrinol Metab 89 (2004), 6239–6243.
28. 28 Zamudio, S., Kovalenko, O., Echalar, L., et al. Evidence for extraplacental sources of circulating angiogenic growth effectors in human pregnancy. Placenta 34 (2013), 1170–1176.
29. 29 Holme, A.M., Roland, M.C., Lorentzen, B., Michelsen, T.M., Henriksen, T., Placental glucose transfer: a human in vivo study. PLoS One, 10, 2015, e0117084.
30. 30 Skjaerven, R., Gjessing, H.K., Bakketeig, L.S., Birthweight by gestational age in Norway. Acta Obstet Gynecol Scand 79 (2000), 440–449.
31. 31 Romero, R., Nien, J.K., Espinoza, J., et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 21 (2008), 9–23.
32. 32 Aird, W.C., Endothelial cell heterogeneity. Cold Spring Harb Perspect Med, 2, 2012, a006429.
33. 33 Law, L.W., Sahota, D.S., Chan, L.W., Chen, M., Lau, T.K., Leung, T.Y., Effect of long-term storage on placental growth factor and fms-like tyrosine kinase 1 measurements in samples from pregnant women. J Matern Fetal Neonatal Med 23 (2010), 1475–1480.